Advertisement

 

 

A Once-Weekly Diabetes Medication

Advertisement

Exenatide extended-release for injectable suspension (Bydureon, Amylin) has been approved by the FDA as a once-weekly treatment for type 2 diabetes. The glucagon-like peptide-1 receptor agonist is indicated as an adjunct to diet and exercise to improve glycemic control in adults.

Source: Amylin.

Submit a Comment

Your email address will not be published. Required fields are marked *

five × three =

[ HIDE/SHOW ]